XML 158 R49.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

(LOSS) EARNINGS PER SHARE (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Earnings Per Share [Abstract] |
Schedule of calculation of earnings per share | (Loss) earnings per share attributable to Bausch Health Companies Inc. for 2019, 2018 and 2017 were calculated as follows:
(in millions, except per share amounts) |  | 2019 |  | 2018 |  | 2017
Net (loss) income attributable to Bausch Health Companies Inc. |  | $ | (1,788 | ) |  | $ | (4,148 | ) |  | $ | 2,404 |
Basic weighted-average number of common shares outstanding |  | 352.1 |  |  | 351.3 |  |  | 350.2 |
Dilutive effect of stock options, RSUs and other |  | — |  |  | — |  |  | 1.6 |
Diluted weighted-average number of common shares outstanding |  | 352.1 |  |  | 351.3 |  |  | 351.8 |
(Loss) earnings per share attributable to Bausch Health Companies Inc. |  |  |  |  |  |
Basic |  | $ | (5.08 | ) |  | $ | (11.81 | ) |  | $ | 6.86 |
Diluted |  | $ | (5.08 | ) |  | $ | (11.81 | ) |  | $ | 6.83 |

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration